Phase I clinical trial of Zevalin (90Y-ibritumomab) in patients with B-cell non-Hodgkin's lymphoma (NHL) with relapsed disease following high-dose chemotherapy and autologous stem cell transplantation (ASCT).

被引：0
|
作者：
Vose, JM
Bierman, PJ
Lynch, JC
Bociek, GR
Multani, PS
Armitage, JO
机构：
[1] IDEC Corp, San Diego, CA USA
[2] Univ Nebraska, Med Ctr, Omaha, NE USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
92
引用
收藏
页码：30A / 30A
页数：1
相关论文
共 50 条
  • [31] Zevalin therapy of a non-Hodgkin relapsed lymphoma patient following an autologous peripheral stem cell transplantation
    Rejto, L
    Boda, Z
    Telek, B
    Kiss, A
    Masszi, T
    Udvardy, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S347 - S348
  • [32] Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL)
    Jagadeesh, Deepa
    Rybicki, Lisa
    Abounader, Lonna
    Liu, Hein
    Dean, Robert M.
    Hill, Brian T.
    Sobecks, Ronald M.
    Gerds, Aaron
    Hamilton, Betty Ky
    Pohlman, Brad
    Kalaycio, Matt E.
    Bolwell, Brian
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S224 - S225
  • [33] Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
    Chiara Ciochetto
    Barbara Botto
    Roberto Passera
    Marilena Bellò
    Giulia Benevolo
    Carola Boccomini
    Alessia Castellino
    Annalisa Chiappella
    Roberto Freilone
    Maura Nicolosi
    Lorella Orsucci
    Clara Pecoraro
    Patrizia Pregno
    Gianni Bisi
    Umberto Vitolo
    Annals of Hematology, 2018, 97 : 1619 - 1626
  • [34] Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
    Ciochetto, Chiara
    Botto, Barbara
    Passera, Roberto
    Bello, Marilena
    Benevolo, Giulia
    Boccomini, Carola
    Castellino, Alessia
    Chiappella, Annalisa
    Freilone, Roberto
    Nicolosi, Maura
    Orsucci, Lorella
    Pecoraro, Clara
    Pregno, Patrizia
    Bisi, Gianni
    Vitolo, Umberto
    ANNALS OF HEMATOLOGY, 2018, 97 (09) : 1619 - 1626
  • [35] Evaluation of baseline body-weight dosing of yttrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) radioimmunotherapy in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).
    Wiseman, G
    Conti, P
    Vo, K
    Schilder, RJ
    Foster, P
    Gordon, LI
    Emmanouilides, C
    Silverman, D
    Witzig, TE
    Molina, A
    BLOOD, 2004, 104 (11) : 721A - 721A
  • [36] High-dose chemotherapy and autologous stem cell transplantation for Korean patients with relapsed or refractory Hodgkin's lymphoma
    Park, K.
    Yoon, D.
    Kim, S.
    Huh, J.
    Park, C.
    Lee, S.
    Park, S.
    Ahn, Y.
    Jo, J.
    Suh, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S445 - S445
  • [37] Radioimmunotherapy with 90Y Ibritumomab Tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
    Olivas, C.
    Bello, P.
    Vercher, J. L.
    Loaiza, J. L.
    Marti, J. F.
    Hervas, I.
    Rivas, A.
    Ruiz, C.
    Perez-Velasco, R.
    Mateo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [38] High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin's lymphomas (NHL).
    Srour, Samer Ali
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Anderlini, Paolo
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Hosing, Chitra
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] HIGH-DOSE VERSUS STANDARD-DOSE RITUXIMAB WITH BEAM IN AUTOLOGOUS STEM CELL TRANSPLANTATION (SCT) FOR RELAPSED AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMAS (NHL)
    Srour, S. A.
    Lozano, S.
    Nieto, Y.
    Alousi, A. M.
    Popat, U. R.
    Quazilbash, M. H.
    Anderlini, P.
    Kebriaei, P.
    Shpall, E.
    Champlin, R. E.
    Hosing, C.
    HAEMATOLOGICA, 2016, 101 : 114 - 114
  • [40] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345